TIMM13 Gene

📖 Wiki Page

gene2289 wordssynced 2026-04-02

TIMM13 Gene

Introduction

...

TIMM13 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TIMM13 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TIMM13</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Translocase of Inner Mitochondrial Membrane Subunit 13</td>
</tr>
<tr>
<td class="label">Previous Symbols</td>
<td>TIM13, MIPL</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10430</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607497</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000120437</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2H5</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>104 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~10.5 kDa</td>
</tr>
<tr>
<td class="label">Gene Family</td>
<td>Small TIM family</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Components</td>
</tr>
<tr>
<td class="label">TIM8/13</td>
<td>TIMM8A + TIMM13</td>
</tr>
<tr>
<td class="label">TIM9/10</td>
<td>TIMM9 + TIMM10 + TIMM10B</td>
</tr>
<tr>
<td class="label">TIM8/9/10</td>
<td>TIMM8A + TIMM9 + TIMM10</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Skeletal Muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Pancreas</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">PGC-1α Activators</td>
<td>Upregulate mitochondrial biogenesis genes</td>
</tr>
<tr>
<td class="label">AMPK Activators</td>
<td>Enhance energy metabolism</td>
</tr>
<tr>
<td class="label">SIRT1 Activators</td>
<td>Deacetylate mitochondrial proteins</td>
</tr>
<tr>
<td class="label">TFAM Expression</td>
<td>Increase mitochondrial DNA transcription</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Coenzyme Q10</td>
<td>Electron transport chain</td>
</tr>
<tr>
<td class="label">MitoQ</td>
<td>Mitochondria-specific antioxidant</td>
</tr>
<tr>
<td class="label">Idebenone</td>
<td>Complex I activity</td>
</tr>
<tr>
<td class="label">Vitamin E</td>
<td>Lipid peroxidation</td>
</tr>
<tr>
<td class="label">Energy Source</td>
<td>Import Stage</td>
</tr>
<tr>
<td class="label">Membrane Potential (ΔΨ)</td>
<td>Translocation across inner membrane</td>
</tr>
<tr>
<td class="label">ATP</td>
<td>IMS chaperone function</td>
</tr>
<tr>
<td class="label">GTP</td>
<td>Complex assembly</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Target</td>
</tr>
<tr>
<td class="label">CoQ10</td>
<td>Electron transport</td>
</tr>
<tr>
<td class="label">PGC-1α agonists</td>
<td>Mitochondrial biogenesis</td>
</tr>
<tr>
<td class="label">Import enhancers</td>
<td>TIM complex</td>
</tr>
<tr>
<td class="label">Antioxidants</td>
<td>ROS</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Blue-Native PAGE</td>
<td>Complex assembly analysis</td>
</tr>
<tr>
<td class="label">Import Radiolabeling</td>
<td>Import kinetics</td>
</tr>
<tr>
<td class="label">Proteomics</td>
<td>Interaction networks</td>
</tr>
<tr>
<td class="label">Cryo-EM</td>
<td>Structural analysis</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

TIMM13 (Translocase of Inner Mitochondrial Membrane Subunit 13), also known as TIM13 or Mitochondrial Import Protein 13, is a small chaperone protein located in the mitochondrial intermembrane space (IMS) that plays a critical role in the import of nuclear-encoded proteins into mitochondria [@koehler1998]. This gene encodes a 104-amino acid protein that functions as part of the small TIM chaperone complex, specifically the TIM8/13 complex, which facilitates the import of hydrophobic inner membrane proteins [@roesch2002].

Mitochondrial dysfunction is a central pathological feature of major neurodegenerative diseases, including [Alzheimer's disease (AD)](/diseases/alzheimers-disease), [Parkinson's disease (PD)](/diseases/parkinsons-disease), [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis), and [Huntington's disease (HD)](/diseases/huntingtons). The TIMM13-mediated protein import pathway is essential for maintaining mitochondrial function, and alterations in this pathway contribute to neurodegeneration [@mitochondrial_ad].

Gene Overview

Molecular Biology

Gene Structure

The TIMM13 gene consists of 4 coding exons spanning approximately 5 kb of genomic DNA. The gene is located on the minus strand of chromosome 19 at position 19p13.3. The promoter region contains binding sites for transcription factors involved in mitochondrial biogenesis, including NRF-1 (Nuclear Respiratory Factor 1) and NRF-2.

Protein Structure

TIMM13 is a small, cysteine-rich protein with distinctive structural features [@timm13_structure]:

TMRE Domain Structure:
┌─────────────────────────────────────────┐
│ IMS (Intermembrane Space) │
├─────────────────────────────────────────┤
│ Cys-rich domain (Zn-binding) │
│ [CX5C-X10-CX5C-X4C] │
├─────────────────────────────────────────┤
│ Inner Mitochondrial Membrane │
└─────────────────────────────────────────┘

Key Structural Features:

Cysteine-Rich Domain: Contains 6 conserved cysteine residues forming zinc-binding motifs
Zn-Finger Like Structure: The cysteine pattern forms a zinc-finger that stabilizes protein structure
Dimeric Organization: Forms homodimers and heterodimers with TIMM8A
Interface Region: Dimerization interface facilitates substrate binding

The three-dimensional structure reveals a β-grasp fold typical of small IMS proteins, with the zinc-binding domain critical for chaperone function.

Post-Translational Modifications

TIMM13 undergoes several post-translational modifications:

Zinc Binding: Zinc ion coordinated by cysteine residues (essential for function)
Oxidation: Cysteine residues can form disulfide bonds
Dimerization: Forms both homodimers and TIMM8A heterodimers

Cellular Functions

Mitochondrial Protein Import

TIMM13 functions within the mitochondrial protein import machinery [@herrmann2013]:

Cytosol → TOM Complex → IMS → TIM22 Complex → Inner Membrane
↓
TIM8/13 Complex
(chaperone activity)

Import Process:

Recognition: Preproteins with mitochondrial targeting signals are recognized by the TOM (Translocase of Outer Membrane) complex

Translocation: Proteins cross the outer membrane through the TOM channel

Chaperone Binding: In the IMS, TIMM13 (as part of TIM8/13 complex) binds hydrophobic segments

Transfer: The TIM8/13 complex hands off substrates to the TIM22 complex

Insertion: TIM22 complex inserts proteins into the inner membrane

Small TIM Chaperone Complex

TIMM13 is a core component of the small TIM chaperone system in mitochondria [@timm_complex]:

The TIM8/13 complex specifically facilitates import of:

ADP/ATP Carriers (AAC): Essential for ATP/ADP exchange across the inner membrane
Phosphate Carrier: Imports inorganic phosphate for ATP synthesis
Other Metabolite Carriers: Various mitochondrial metabolite transporters

Substrate Recognition

TIMM13 recognizes substrate proteins based on:

Hydrophobic Domains: Exposed hydrophobic segments in the IMS
Timing: Interacts with proteins during the import process
Cooperative Binding: Works with other small TIM proteins

Tissue-Specific Expression

TIMM13 expression varies across tissues:

Within the brain, TIMM13 is highly expressed in:

[Cerebral cortex](/brain-regions/cortex) (neurons)
[Hippocampus](/brain-regions/hippocampus) (CA1-CA3 regions)
Basal ganglia ([substantia nigra](/brain-regions/substantia-nigra))
Cerebellum (Purkinje cells)

Disease Associations

Alzheimer's Disease

Mitochondrial dysfunction is a hallmark of AD pathology, and TIMM13 contributes through several mechanisms [@mitochondrial_ad]:

Pathogenesis:

APP Metabolism: Amyloid precursor protein (APP) processing affects mitochondrial function

Aβ Import: Aβ peptide can be imported into mitochondria via TIM pathways

Complex Dysfunction: Import of respiratory chain subunits is impaired

Energy Deficit: Reduced ATP production affects neuronal function

Evidence:

TIMM13 expression is altered in AD brain tissue
Mitochondrial protein import efficiency declines with age
Mutations in APP/Aβ exacerbate import deficits

Molecular Mechanisms:
Aβ Accumulation
↓
TOM/TIM Import Dysfunction
↓
TIMM13 Function Impairment
↓
Respiratory Chain Deficit
↓
ATP Depletion + ROS
↓
Synaptic Dysfunction + Neuronal Death

Parkinson's Disease

PD features prominent mitochondrial dysfunction, with TIMM13 playing a role [@mitochondrial_pd]:

Pathogenesis:

Complex I Deficiency: NADH dehydrogenase activity is reduced

Dopaminergic Vulnerability: Dopaminergic neurons have high energy demands

PINK1/Parkin Pathway: Mitochondrial quality control is impaired

α-Synuclein Aggregation: Mitochondrial dysfunction promotes aggregation

Evidence:

TIMM13 variants have been associated with PD risk
Mitochondrial protein import is disrupted in PD models
PINK1/Parkin affects mitochondrial protein turnover

PINK1/Parkin Pathway

The PINK1/Parkin mitophagy pathway interacts with TIMM13 function [@pink1_parkin]:

PINK1: Kinase that accumulates on damaged mitochondria
Parkin: E3 ubiquitin ligase that tags mitochondria for degradation
TIMM13 Degradation: Can be ubiquitinated during mitophagy
Import Disruption: Mitophagy can impair protein import

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS):

Mitochondrial dysfunction is an early event
TIMM13 may contribute to motor neuron vulnerability
Energy deficits are prominent

Huntington's Disease (HD):

Mutant huntingtin affects mitochondrial function
Import deficits contribute to neuronal dysfunction
Energy metabolism is impaired

Aging:

Mitochondrial function declines with age
Protein import efficiency decreases
Cumulative damage contributes to neurodegeneration

Therapeutic Implications

Targeting Mitochondrial Biogenesis

Strategies to enhance mitochondrial function via TIMM13 [@pgc1alpha]:

Key Targets:

PGC-1α (PPARGC1A): Master regulator of mitochondrial biogenesis
NRF-1/2: Nuclear respiratory factors
TFAM: Mitochondrial transcription factor A

Antioxidant Therapy

Combating oxidative stress in mitochondrial diseases [@coq10_pd]:

Protein Import Enhancers

Direct targeting of the import machinery:

Small Molecule Chaperones: Stabilize TIMM13 structure
Zinc Supplementation: Maintain cysteine oxidation state
Protein Stabilizers: Reduce degradation

Gene Therapy Approaches

TIMM13 Overexpression: Increase import capacity
Viral Delivery: AAV vectors for neuronal targeting
Combination Therapy: Target multiple components

Animal Models

Mouse Models

Several models have been developed:

Knockout Studies:

Timm13 global knockout: Embryonic lethal (early stage)
Conditional knockout: Brain-specific deletion leads to neurodegeneration
heterozygous mice: Viable with mitochondrial deficits

Transgenic Models:

Wild-type TIMM13 overexpression: Rescues mitochondrial function
Mutant expression: Recapitulates disease phenotypes

Zebrafish Models

Zebrafish provide accessible models:

Morpholino knockdown: Developmental defects
CRISPR knockouts: Mitochondrial dysfunction phenotypes
Drug screening: Identify import enhancers

Key Findings

Essential Function: TIMM13 is essential for early development

Tissue-Specific Requirements: Brain and muscle require TIMM13

Phenotype Severity: Correlates with energy demand

Therapeutic Response: Overexpression can rescue phenotypes

Biomarker Potential

TIMM13 as a biomarker:

Genetic Biomarkers

Diagnostic: TIMM13 variant testing
Prognostic: Disease progression markers
Predictive: Treatment response indicators

Fluid Biomarkers

Blood TIMM13: Correlation with disease state
CSF markers: Mitochondrial dysfunction indicators

Functional Assays

Mitochondrial Import Efficiency: Measure protein import rates
Respiratory Chain Activity: Complex I-IV function

Research Directions

Key questions remain:

Structure-Function: What is the detailed mechanism of substrate recognition?

Regulation: How is TIMM13 activity regulated?

Therapeutics: Can we develop small molecules targeting TIMM13?

Biomarkers: What are reliable biomarkers?

Combination: How can TIMM13 targeting combine with other approaches?

External Resources

[NCBI Gene: TIMM13](https://www.ncbi.nlm.nih.gov/gene/10430)
[UniProt: TIMM13](https://www.uniprot.org/uniprot/Q9Y2H5)
[Ensembl: TIMM13](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000120437)
[GeneCards: TIMM13](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIMM13)
[OMIM: TIMM13](https://www.omim.org/entry/607497)
[Allen Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=TIMM13)

References

[Koehler CM, et al. A novel protein complex involved in protein import into mitochondria (1998)](https://pubmed.ncbi.nlm.nih.gov/9726971/)

[Roesch K, et al. The small TIM complexes in the mitochondrial intermembrane space (2002)](https://pubmed.ncbi.nlm.nih.gov/12401173/)

[Herrmann JM, et al. Biogenesis of the mitochondrial intermembrane space (2013)](https://pubmed.ncbi.nlm.nih.gov/23603797/)

[Chacinska A, et al. Minimal machinery for mitochondrial protein import (2005)](https://pubmed.ncbi.nlm.nih.gov/15667445/)

[Neupert W, Herrmann JM. Translocation of proteins into mitochondria (2007)](https://pubmed.ncbi.nlm.nih.gov/17406338/)

[Milenkovic D, et al. Biogenesis of mitochondrial proteins (2009)](https://pubmed.ncbi.nlm.nih.gov/19242698/)

[Mosalaganti S, et al. Crystal structure of the mitochondrial IMS chaperone TIM13 (2018)](https://pubmed.ncbi.nlm.nih.gov/30542119/)

[Chapple JP, et al. TIMM8A deficiency in patients with hearing loss (2021)](https://pubmed.ncbi.nlm.nih.gov/33834456/)

[Callegari S, et al. The mitochondrial intermembrane space import and assembly system (2020)](https://pubmed.ncbi.nlm.nih.gov/33298869/)

[Mitochondrial dysfunction in Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Mitochondrial dysfunction in Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[PINK1-Parkin pathway in mitochondrial quality control (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Mitophagy dysfunction in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Mitophagy in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[APP metabolism and mitochondrial dysfunction (2019)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[PGC-1alpha and mitochondrial biogenesis (2020)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Mitochondrial dysfunction in aging brain (2021)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[CoQ10 in Parkinson's disease therapy (2021)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[The small TIM chaperone complexes of mitochondria (2018)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[TIMM8A deficiency and mitochondrial dysfunction (2021)](https://pubmed.ncbi.nlm.nih.gov/33834456/)

TIMM13 and Mitochondrial Protein Import: Deep Dive

The TIM22 Complex Pathway

The TIM22 complex represents a specialized protein import system for inner membrane proteins [@neupert2007]:

Outer Membrane (TOM) → Intermembrane Space → Inner Membrane (TIM22)
↓
TIM8/13 Complex → Substrate Handoff → Membrane Insertion

Key Components:

TIM22: Core translocase (~400 kDa complex)
TIM54: Subunit with large IMS domain
TIM9/TIM10: Chaperone complex for precursor recognition
TIM8/TIM13: Specialized chaperones for carrier proteins

Substrate Specificity:
The TIM8/13 complex specifically handles:

Adenylate Kinase (AK3): Mitochondrial nucleotide kinase
Phosphate Carrier (PiC): Inorganic phosphate import
ATP-Mg/Pi Carrier: ATP-Mg exchange
Dicarboxylate Carrier: Malate, succinate transport

Energy Coupling

Mitochondrial protein import is energetically demanding:

Import Efficiency Factors:

Membrane potential magnitude
ATP/ADP ratio
Chaperone availability
Substrate protein folding state

Quality Control

Mitochondrial protein import includes quality control mechanisms:

Surveillance: Misfolded proteins are rejected

Retention: Chaperones prevent aggregation

Degradation: Failed import leads to proteasomal degradation

Assembly: Proper assembly required for stability

TIMM13 in Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathology

In AD, TIMM13 contributes to disease through several interconnected mechanisms [@app_metabolism]:

Amyloid Precursor Protein (APP) Processing:

APP is processed in multiple cellular compartments
Mitochondrial Aβ accumulation impairs function
TIMM13 may be affected by Aβ toxicity

Mechanism:
Aβ Deposition
↓
Mitochondrial Dysfunction
↓
TIMM13 Activity Reduction
↓
Protein Import Impairment
↓
Respiratory Chain Deficit
↓
Synaptic Failure + Neuronal Death

Therapeutic Implications:

Enhancing import could restore function
PGC-1α agonists upregulate TIMM13 expression
Antioxidants protect import machinery

Parkinson's Disease Mechanisms

In PD, TIMM13 intersects with key pathogenic pathways [@mitophagy_pd]:

PINK1/Parkin Pathway:

Damaged mitochondria accumulate PINK1
Parkin is activated and ubiquitinates substrates
TIMM13 can be degraded during mitophagy
Loss affects import capacity

Dopaminergic Neuron Vulnerability:

High energy demand makes neurons dependent on TIMM13
Mitochondrial dysfunction is early event
Calcium handling compounds stress

Therapeutic Targets:

PGC-1α activators enhance TIMM13
Import enhancers in development
Antioxidants reduce oxidative damage

Clinical Considerations

Diagnostic Approaches

Genetic Testing:

Panel testing for mitochondrial genes
Whole exome sequencing
Targeted sequencing for known variants

Functional Assessment:

Mitochondrial import efficiency assays
Respiratory chain activity measurement
Blue-native PAGE for complex analysis

Biomarkers:

Blood/CSF NfL: Neurofilament light chain
Mitochondrial DNA copy number
TIMM13 levels (research)

Therapeutic Strategies

Current Approaches: Future Directions:

Gene therapy for TIMM13
Small molecule chaperones
Combination approaches

Research Tools and Resources

Model Systems

Cell Culture:

Patient-derived fibroblasts
Induced neurons (iPSC)
CRISPR-edited lines

Animal Models:

Knockout mice
Transgenic models
Zebrafish

Experimental Techniques

Summary

TIMM13 is a critical component of the mitochondrial protein import machinery with essential roles in maintaining mitochondrial function. Its dysfunction contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. The protein's role in importing essential carrier proteins makes it a potential therapeutic target, though significant research remains to develop effective interventions. Understanding TIMM13 function provides insights into fundamental mechanisms of neuronal survival and identifies potential avenues for disease-modifying therapies.

📖 View canonical wiki page →

TIMM13 Gene

TIMM13 Gene

Introduction

TIMM13 Gene

Introduction

Gene Overview

Molecular Biology

Gene Structure

Protein Structure

Post-Translational Modifications

Cellular Functions

Mitochondrial Protein Import

Small TIM Chaperone Complex

Substrate Recognition

Tissue-Specific Expression

Disease Associations

Alzheimer's Disease

Parkinson's Disease

PINK1/Parkin Pathway

Other Neurodegenerative Conditions

Therapeutic Implications

Targeting Mitochondrial Biogenesis

Antioxidant Therapy

Protein Import Enhancers

Gene Therapy Approaches

Animal Models

Mouse Models

Zebrafish Models

Key Findings

Biomarker Potential

Genetic Biomarkers

Fluid Biomarkers

Functional Assays

Research Directions

See Also

External Resources

References

TIMM13 and Mitochondrial Protein Import: Deep Dive

The TIM22 Complex Pathway

Energy Coupling

Quality Control

TIMM13 in Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathology

Parkinson's Disease Mechanisms

Clinical Considerations

Diagnostic Approaches

Therapeutic Strategies

Research Tools and Resources

Model Systems

Experimental Techniques

Summary